Bilateral acute anterior uveitis: a rare ocular side effect of erlotinib
Sign Up to like & getrecommendations! Published in 2019 at "BMJ Case Reports"
DOI: 10.1136/bcr-2019-232868
Abstract: Erlotinib used in the treatment of advanced non-small cell lung cancer (NSCLC) is a first-generation small-molecule tyrosine kinase inhibitor which reversibly inhibits the kinase domain of epithelial growth factor receptor (EGFR). The incidence of ocular… read more here.
Keywords: aau; uveitis rare; anterior uveitis; acute anterior ... See more keywords